| J0897 | Injection, denosumab, 1 mg | 15,060 | $20 | $271.1K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 25,200 | $10 | $201.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 920 | $110 | $99.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,600 | $10 | $66K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,760 | $30 | $49.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,540 | $30 | $40K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,800 | $1 | $35.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $120 | $21.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 300 | $70 | $20.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 160 | $80 | $12K |